Hemenway Trust Hemenway Trust’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $565K | Sell |
3,700
-230
| -6% | -$35.3K | 0.05% | 78 |
|
|
2025
Q4 | $542K | Sell |
3,930
-180
| -4% | -$23.6K | 0.04% | 79 |
|
|
2025
Q3 | $527K | Sell |
4,110
-25
| -0.6% | -$3.05K | 0.04% | 84 |
|
|
2025
Q2 | $500K | Sell |
4,135
-1,268
| -23% | -$143K | 0.04% | 88 |
|
|
2025
Q1 | $602K | Sell |
5,403
-1,451
| -21% | -$154K | 0.05% | 77 |
|
|
2024
Q4 | $667K | Sell |
6,854
-4,335
| -39% | -$462K | 0.05% | 74 |
|
|
2024
Q3 | $1.29M | Sell |
11,189
-8,791
| -44% | -$997K | 0.1% | 61 |
|
|
2024
Q2 | $2.13M | Sell |
19,980
-69,731
| -78% | -$7M | 0.18% | 46 |
|
|
2024
Q1 | $8.68M | Sell |
89,711
-72,114
| -45% | -$7.39M | 0.75% | 32 |
|
|
2023
Q4 | $16.3M | Sell |
161,825
-30,187
| -16% | -$2.91M | 1.56% | 26 |
|
|
2023
Q3 | $19.6M | Buy |
192,012
+205
| +0.1% | +$20.8K | 2.05% | 23 |
|
|
2023
Q2 | $19.4M | Buy |
191,807
+4,810
| +3% | +$481K | 1.9% | 25 |
|
|
2023
Q1 | $17.2M | Buy |
186,997
+2,080
| +1% | +$182K | 1.82% | 25 |
|
|
2022
Q4 | $16.8M | Sell |
184,917
-3,825
| -2% | -$322K | 1.87% | 23 |
|
|
2022
Q3 | $14.3M | Sell |
188,742
-468
| -0.2% | -$38.8K | 1.69% | 25 |
|
|
2022
Q2 | $16M | Sell |
189,210
-14,396
| -7% | -$1.26M | 1.82% | 24 |
|
|
2022
Q1 | $17.9M | Sell |
203,606
-3,771
| -2% | -$327K | 1.72% | 24 |
|
|
2021
Q4 | $18.1M | Sell |
207,377
-13,054
| -6% | -$1.08M | 1.65% | 29 |
|
|
2021
Q3 | $18M | Sell |
220,431
-5,384
| -2% | -$484K | 1.82% | 25 |
|
|
2021
Q2 | $20.6M | Sell |
225,815
-3,434
| -1% | -$306K | 2.08% | 21 |
|
|
2021
Q1 | $19.6M | Buy |
229,249
+7,342
| +3% | +$659K | 2.14% | 21 |
|
|
2020
Q4 | $21M | Buy |
221,907
+5,235
| +2% | +$457K | 2.4% | 20 |
|
|
2020
Q3 | $18.8M | Buy |
216,672
+1,402
| +0.7% | +$121K | 2.45% | 16 |
|
|
2020
Q2 | $18.8M | Buy |
215,270
+4,069
| +2% | +$351K | 2.61% | 16 |
|
|
2020
Q1 | $17.4M | Buy |
211,201
+4,907
| +2% | +$438K | 2.94% | 11 |
|
|
2019
Q4 | $19.5M | Buy |
206,294
+1,221
| +0.6% | +$110K | 2.81% | 12 |
|
|
2019
Q3 | $17.8M | Buy |
205,073
+1,549
| +0.8% | +$139K | 2.79% | 15 |
|
|
2019
Q2 | $18.6M | Sell |
203,524
-22,000
| -10% | -$1.86M | 2.87% | 12 |
|
|
2019
Q1 | $19.4M | Buy |
225,524
+23,022
| +11% | +$1.85M | 3.13% | 10 |
|
|
2018
Q4 | $15.6M | Sell |
202,502
-12,808
| -6% | -$997K | 3.18% | 9 |
|
|
2018
Q3 | $16.6M | Buy |
215,310
+5,481
| +3% | +$405K | 2.8% | 12 |
|
|
2018
Q2 | $14.2M | Buy |
209,829
+12,146
| +6% | +$838K | 2.62% | 13 |
|
|
2018
Q1 | $14.3M | Buy |
197,683
+7,836
| +4% | +$597K | 2.72% | 13 |
|
|
2017
Q4 | $14.3M | Buy |
189,847
+8,734
| +5% | +$659K | 2.72% | 13 |
|
|
2017
Q3 | $13.9M | Buy |
181,113
+4,873
| +3% | +$368K | 2.91% | 11 |
|
|
2017
Q2 | $13.2M | Buy |
176,240
+7,645
| +5% | +$542K | 2.93% | 10 |
|
|
2017
Q1 | $11.2M | Buy |
168,595
+17,577
| +12% | +$1.17M | 2.58% | 12 |
|
|
2016
Q4 | $9.86M | Buy |
151,018
+842
| +0.6% | +$54.6K | 2.49% | 12 |
|
|
2016
Q3 | $10.6M | Buy |
150,176
+3,058
| +2% | +$223K | 2.66% | 12 |
|
|
2016
Q2 | $10.9M | Buy |
147,118
+6,506
| +5% | +$449K | 2.84% | 9 |
|
|
2016
Q1 | $9.13M | Buy |
140,612
+1,570
| +1% | +$107K | 2.46% | 13 |
|
|
2015
Q4 | $10.7M | Buy |
139,042
+4,162
| +3% | +$331K | 2.83% | 7 |
|
|
2015
Q3 | $11.1M | Buy |
134,880
+3,331
| +3% | +$296K | 3.07% | 6 |
|
|
2015
Q2 | $11.6M | Buy |
131,549
+4,799
| +4% | +$440K | 2.98% | 4 |
|
|
2015
Q1 | $11.2M | Buy |
126,750
+3,253
| +3% | +$289K | 2.93% | 5 |
|
|
2014
Q4 | $10.3M | Buy |
123,497
+4,308
| +4% | +$357K | 3.07% | 8 |
|
|
2014
Q3 | $10.1M | Buy |
119,189
+729
| +0.6% | +$59K | 3.14% | 3 |
|
|
2014
Q2 | $9.61M | Buy |
118,460
+3,913
| +3% | +$308K | 2.92% | 5 |
|
|
2014
Q1 | $8.73M | Sell |
114,547
-162
| -0.1% | -$11.8K | 2.75% | 6 |
|
|
2013
Q4 | $8.26M | Buy |
114,709
+965
| +0.8% | +$67.1K | 2.65% | 6 |
|
|
2013
Q3 | $7.82M | Buy |
113,744
+3,960
| +4% | +$262K | 2.91% | 4 |
|
|
2013
Q2 | $6.96M | Buy |
+109,784
| New | +$7.14M | 2.97% | 6 |
|
Other funds holding NVS
Hemenway Trust Hemenway Trust's NVS Position: Q1 2026 in Review
Hemenway Trust Hemenway Trust reduced its Novartis (NVS) stake by 5.9% in Q1 2026, selling an estimated $35.3K and leaving 3,700 shares worth $565K. The position accounts for 0.05% of the portfolio, ranked #78.
Hemenway Trust Hemenway Trust first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $21M in Q4 2020. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Hemenway Trust Hemenway Trust held 3,700 shares of Novartis worth $565K as of Q1 2026.
- Hemenway Trust Hemenway Trust sold 230 Novartis shares in Q1 2026, an estimated $35.3K.
- Novartis made up 0.05% of Hemenway Trust Hemenway Trust's portfolio in Q1 2026, its #78 holding.
- Hemenway Trust Hemenway Trust first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Hemenway Trust Hemenway Trust's Novartis position peaked at $21M in Q4 2020.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2026, filed 7 May 2026.